<?xml version='1.0' encoding='utf-8'?>
<document id="22037888"><sentence text="Provider and pharmacist responses to warfarin drug-drug interaction alerts: a study of healthcare downstream of CPOE alerts." /><sentence text="To categorize the appropriateness of provider and pharmacist responses to warfarin critical drug-drug interaction (cDDI) alerts, assess responses and actions to the cDDI, and determine the occurrence of warfarin adverse drug events (ADE) after alerts" /><sentence text="" /><sentence text="An 18-month, retrospective study of acute care admissions at a single Veterans Affairs medical center using computerized provider order entry (CPOE)" /><sentence text="" /><sentence text="Patients included had at least one warfarin cDDI alert" /><sentence text=" Chart reviews included baseline laboratory values and demographics, provider actions, patient outcomes, and associated factors, including other interacting medications and number of simultaneously processed alerts" /><sentence text="" /><sentence text="137 admissions were included (133 unique patients)" /><sentence text=" Amiodarone, vitamin E in a multivitamin, sulfamethoxazole, and levothyroxine accounted for 75% of warfarin cDDI"><entity charOffset="1-11" id="DDI-PubMed.22037888.s10.e0" text="Amiodarone" /><entity charOffset="13-22" id="DDI-PubMed.22037888.s10.e1" text="vitamin E" /><entity charOffset="42-58" id="DDI-PubMed.22037888.s10.e2" text="sulfamethoxazole" /><entity charOffset="64-77" id="DDI-PubMed.22037888.s10.e3" text="levothyroxine" /><pair ddi="false" e1="DDI-PubMed.22037888.s10.e0" e2="DDI-PubMed.22037888.s10.e0" /><pair ddi="false" e1="DDI-PubMed.22037888.s10.e0" e2="DDI-PubMed.22037888.s10.e1" /><pair ddi="false" e1="DDI-PubMed.22037888.s10.e0" e2="DDI-PubMed.22037888.s10.e2" /><pair ddi="false" e1="DDI-PubMed.22037888.s10.e0" e2="DDI-PubMed.22037888.s10.e3" /><pair ddi="false" e1="DDI-PubMed.22037888.s10.e1" e2="DDI-PubMed.22037888.s10.e1" /><pair ddi="false" e1="DDI-PubMed.22037888.s10.e1" e2="DDI-PubMed.22037888.s10.e2" /><pair ddi="false" e1="DDI-PubMed.22037888.s10.e1" e2="DDI-PubMed.22037888.s10.e3" /><pair ddi="false" e1="DDI-PubMed.22037888.s10.e2" e2="DDI-PubMed.22037888.s10.e2" /><pair ddi="false" e1="DDI-PubMed.22037888.s10.e2" e2="DDI-PubMed.22037888.s10.e3" /></sentence><sentence text=" Provider responses were clinically appropriate in 19" /><sentence text="7% of admissions and pharmacist responses were appropriate in 9" /><sentence text="5% of admissions" /><sentence text=" There were 50 ADE (36" /><sentence text="6% of admissions) with warfarin; 80% were rated as having no or mild clinical effect" /><sentence text=" An increased number of non-critical alerts at the time of the reference cDDI alert was the only variable associated with an inappropriate provider response (p=0" /><sentence text="01)" /><sentence text="" /><sentence text="This study was limited by being a retrospective review and the possibility of confounding variables, such as other interacting medications" /><sentence text="" /><sentence text="The large number of CPOE alerts may lead to inappropriate responses by providers and pharmacists" /><sentence text=" The high rate of ADE suggests a need for improved medication management systems for patients on warfarin" /><sentence text=" This study highlights the possibility of alert fatigue contributing to the high prevalence of inappropriate alert over-ride text responses" /><sentence text="" /></document>